Literature DB >> 1989359

Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.

P Belitsky1, A S MacDonald, A D Cohen, J Crocker, D Hirsch, K Jindal, J Lawen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989359

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

Review 1.  Immunosuppressive drugs in renal transplantation. A review of the regimens.

Authors:  J M Barry
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 2.  Immunosuppressive preconditioning or induction regimens : evidence to date.

Authors:  Henkie P Tan; Marc C Smaldone; Ron Shapiro
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

4.  Cadaver kidney transplantation in patients more than 65 years old.

Authors:  J M Barry; M J Lemmers; M M Meyer; A DeMattos; W M Bennett; D J Norman
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 5.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 6.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

7.  Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance.

Authors:  S K Akkina; J J Connaire; A K Israni; J J Snyder; A J Matas; B L Kasiske
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.